ng-nitroarginine methyl ester has been researched along with Cardiomyopathy, Restrictive in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abbate, A; Brown, WR; Das, A; Hoke, NN; Houser, JE; Kukreja, RC; Mudrick, CA; Prabhakar, S; Qureshi, IZ; Roy, SK; Salloum, FN | 1 |
1 other study(ies) available for ng-nitroarginine methyl ester and Cardiomyopathy, Restrictive
| Article | Year |
|---|---|
Sildenafil (Viagra) attenuates ischemic cardiomyopathy and improves left ventricular function in mice.
Topics: Animals; Apoptosis; Blotting, Western; Cardiomegaly; Cardiomyopathy, Restrictive; Coronary Vessels; Echocardiography, Doppler; Enzyme Inhibitors; In Situ Nick-End Labeling; Ligation; Male; Mice; Mice, Inbred ICR; Myocardial Infarction; Necrosis; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Piperazines; Pulmonary Edema; Purines; Sildenafil Citrate; Sulfones; Survival Analysis; Vasodilator Agents; Ventricular Function, Left; Ventricular Remodeling | 2008 |